Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI (BST-AMI)

  • days left to enroll
  • participants needed
  • sponsor
    Shenyang Northern Hospital
Updated on 22 March 2022


Acute myocardial infarction (AMI) is one of the leading causes of death around the world, with the potential for substantial morbidity and mortality. The increasing evidence indicates that exercise training has beneficial effects on LV remodelling in post-MI patients with greater benefits occurring when training earlier following MI, among which the earliest time for rehabilitation is one week after myocardial infarction. However, the effect of Baduanjin sequential therapy for patients after one week of AMI has yet to be assessed. Therefore, the aim of this study is to assess the impact of Baduanjin sequential therapy on cardiac and physical function in patients with AMI and reduced ejection fraction after primary PCI.

Condition AMI
Treatment Aerobic Exercise, Baduanjin sequential therapy
Clinical Study IdentifierNCT05201274
SponsorShenyang Northern Hospital
Last Modified on22 March 2022


Yes No Not Sure

Inclusion Criteria

Acute myocardial infarction undergoing primary percutaneous coronary intervention
Aged 18 years or over and under 80 years
% < LVEF < 50% and LV < 65mm
With informed consents

Exclusion Criteria

Severe symptomatic congestive heart failure (KILLIP cardiac function class III-IV)
Malignant arrhythmias (ventricular fibrillation, ventricular tachycardia, frequent multiple source ventricular premature)
Uncontrolled hypertension (systolic blood pressure greater than 160mmhg, diastolic blood pressure greater than 100mmhg)
Life-threatening diseases with limited life expectancy <6 months
Inability or difficulty to exercise
Participation in other clinical trials
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note